Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
暂无分享,去创建一个
[1] C. Lázaro,et al. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 , 2005, Journal of Medical Genetics.
[2] M. Tatagiba,et al. Screening for large mutations of the NF2 gene , 2005, Genes, chromosomes & cancer.
[3] D. Evans,et al. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. , 2004, American journal of human genetics.
[4] D. Evans,et al. Genotype-phenotype correlations for cataracts in neurofibromatosis 2 , 2003, Journal of medical genetics.
[5] G. Otsuka,et al. Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. , 2003, Journal of neurosurgery.
[6] L. Pizzarello. Incidence of Age-Related Cataract Over a 10-Year Interval: The Beaver Dam Eye Study , 2003 .
[7] L. Kluwe,et al. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas , 2003, Journal of medical genetics.
[8] Ronald Klein,et al. Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. , 2002, Ophthalmology.
[9] D. Evans,et al. Predictors of the risk of mortality in neurofibromatosis 2. , 2002, American journal of human genetics.
[10] S. Richard,et al. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. , 2002, Investigative ophthalmology & visual science.
[11] M. Kaiser-Kupfer,et al. Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2 , 2002, The Journal of pathology.
[12] C. Shields,et al. REVIEW: COATS DISEASE: THE 2001 LUESTHER T. MERTZ LECTURE , 2002, Retina.
[13] A. Berns,et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. , 2000, Genes & development.
[14] L. Kluwe,et al. Germ-line NF2 mutations and disease severity in neurofibromatosis type 2 patients with retinal abnormalities. , 1999, American journal of human genetics.
[15] L. Kluwe,et al. Mosaicism in sporadic neurofibromatosis 2 patients. , 1998, Human molecular genetics.
[16] V. Mautner,et al. The diagnosis and management of neurofibromatosis 2 in childhood. , 1998, Seminars in pediatric neurology.
[17] M. Tatagiba,et al. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene. , 1998, American journal of medical genetics.
[18] S. Pulst,et al. Ocular abnormalities in neurofibromatosis 2. , 1996, American journal of ophthalmology.
[19] M. Kaiser-Kupfer,et al. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. , 1996, American journal of human genetics.
[20] R. Weksberg,et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. , 1996, American journal of human genetics.
[21] S. Pulst,et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. , 1996, Neurosurgery.
[22] S. Pulst,et al. Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity and variety. , 1995, AJR. American journal of roentgenology.
[23] G. Thomas,et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. , 1995, Human molecular genetics.
[24] M I Kaiser-Kupfer,et al. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. , 1994, American journal of medical genetics.
[25] G. Thomas,et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients , 1993, Cell.
[26] S. Pulst,et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.
[27] J. Haines,et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.
[28] M. Kaiser-Kupfer,et al. Visual impairment in patients with neurofibromatosis 2 , 1993, Neurology.
[29] D. Evans,et al. A clinical study of type 2 neurofibromatosis. , 1992, The Quarterly journal of medicine.
[30] P. Mitchell,et al. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. , 2003, Ophthalmology (Rochester, Minn.).
[31] A. Rothner,et al. Retinal changes associated with neurofibromatosis 2. , 1995, Transactions of the American Ophthalmological Society.